The Biotech Innovation Organization on Tuesday named Amicus Therapeutics co-founder and longtime leader John Crowley as its new CEO, taking over a spot interim chief Rachel King has held for the past 14 months. BIO’s decision to name Crowley, who will assume the role effective March 4, as permanent CEO comes just over a year…
Dive Brief: Seattle Children’s Hospital is spinning out a biotechnology startup named BrainChild Bio to develop new cancer drugs for central nervous system tumors, the hospital announced Tuesday. The company is licensing CAR-T technology from Seattle Children’s, and has also received equity funding from the health care provider. Financial terms of the deal were not…
Dive Brief: The Food and Drug Administration granted conditional approval to Eli Lilly’s oral cancer drug Jaypirca in two types of blood cancer, expanding its use from a rare type of lymphoma to people with leukemia and lymphoma patients who have previously received two other treatments, the company said Friday. Jaypirca is the fourth of…
Europe’s drug regulator has more questions about the safety and potential risks of a new, widely popular class of medicines. Known as GLP-1 agonists, the class includes Novo Nordisk’s Ozempic, Wegovy, Rybelsus and Saxenda, as well as Eli Lilly’s Trulicity. These medicines prompt the body to produce insulin, making them effective treatments for diabetes or…
Researchers have massive amounts of real-world healthcare data at our fingertips and when approaching a real-world evidence (RWE) deep analytics task, electronic health records are typically the first stop in terms of data gathering. However, there are a number of other important data sources, including structured data like healthcare claims and unstructured data such as…
With clinical trials becoming more complex, finding ways to streamline and automate laboratory processes is vital when analyzing bioanalytical samples. As the chief scientific officer of large-molecule bioanalysis, Dr. Tom Zhang leverages his expertise to promote ever-evolving automation technologies. He also maintains Worldwide’s knowledge of large-molecule bioanalytical methodologies. He explains that today’s bioanalytical labs are…
